Il y a eu 50 transactions d'initiés récentes enregistrées pour Acasti Pharma Inc. (ACST), dont 35 achats et 7 ventes. Le total des achats d'initiés s'élève à $3.21M et le total des ventes d'initiés à $760.81K.
Les initiés notables ayant une activité récente comprennent Adar1 Capital Management, Llc, Macdonald R. Loch, Delaversano Robert J. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ACST
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-06-28 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Inconnu |
- |
- |
- |
959,571 |
| 2024-05-06 |
Macdonald R. Loch |
Chief Medical Officer |
Attribution de RSU |
25,380 |
$2.96 |
$75.12K |
25,380 |
| 2024-05-06 |
Delaversano Robert J |
Principal Financial Officer |
Attribution de RSU |
4,500 |
$2.96 |
$13.32K |
4,500 |
| 2024-05-06 |
Kohli Prashant |
Chief Executive Officer |
Attribution de RSU |
128,770 |
$2.96 |
$381.16K |
128,770 |
| 2024-05-06 |
D'andrea Carrie |
VP Program Management |
Attribution de RSU |
19,740 |
$2.96 |
$58.43K |
19,740 |
| 2024-05-06 |
Kumar Amresh |
VP Clinical Operations |
Attribution de RSU |
19,740 |
$2.96 |
$58.43K |
19,740 |
| 2024-01-05 |
Delaversano Robert J |
Vice President, Finance |
Cession |
42,000 |
$2.13 |
$89.25K |
- |
| 2023-12-19 |
Davis A Brian |
Director |
Attribution de RSU |
22,500 |
$2.13 |
$47.81K |
22,500 |
| 2023-12-19 |
Neugeboren Edward |
Director |
Attribution de RSU |
22,500 |
$2.13 |
$47.81K |
22,500 |
| 2023-12-19 |
Kavuru Vimal |
10 Percent Owner |
Attribution de RSU |
10,000 |
$2.13 |
$21.25K |
10,000 |
| 2023-12-19 |
Kottayil George |
Director |
Attribution de RSU |
22,500 |
$2.13 |
$47.81K |
22,500 |
| 2023-12-19 |
Kohli Prashant |
Chief Executive Officer |
Attribution de RSU |
41,668 |
$2.13 |
$88.54K |
41,668 |
| 2023-10-10 |
Davis A Brian |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-10-10 |
Neugeboren Edward |
Director |
Cession |
- |
- |
- |
37,895 |
| 2023-10-10 |
Kottayil George |
Director |
Inconnu |
- |
- |
- |
124,344 |
| 2023-09-25 |
Kavuru Vimal |
10 Percent Owner |
Achat Informatif |
422,732 |
$3.00 |
$1.27M |
422,732 |
| 2023-09-25 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Inconnu |
913,631 |
$0.00 |
$91.36 |
- |
| 2023-08-31 |
Olds Donald |
Director |
Achat Informatif |
381 |
$2.05 |
$781.05 |
381 |
| 2023-07-14 |
Macdonald R. Loch |
Chief Medical Officer |
Attribution de RSU |
60,000 |
$2.64 |
$158.4K |
60,000 |
| 2023-07-14 |
Kavuru Vimal |
Director |
Attribution de RSU |
12,500 |
$2.64 |
$33K |
12,500 |
| 2023-07-14 |
Olds Donald |
Director |
Attribution de RSU |
12,500 |
$2.64 |
$33K |
12,500 |
| 2023-07-14 |
Derby Michael |
Director |
Attribution de RSU |
12,500 |
$2.64 |
$33K |
12,500 |
| 2023-07-14 |
Kohli Prashant |
Chief Executive Officer |
Attribution de RSU |
208,334 |
$2.64 |
$550K |
208,334 |
| 2023-07-14 |
D'andrea Carrie |
VP Clinical Operations |
Attribution de RSU |
42,000 |
$2.64 |
$110.88K |
42,000 |
| 2023-07-14 |
Kumar Amresh |
VP Program Management |
Attribution de RSU |
42,000 |
$2.64 |
$110.88K |
42,000 |
| 2023-05-08 |
D'andrea Carrie |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-05-08 |
Kumar Amresh |
VP Program Management |
Cession |
- |
- |
- |
66,712 |
| 2023-05-08 |
Macdonald R. Loch |
Officer |
Inconnu |
- |
- |
- |
- |
| 2022-09-28 |
Canan John |
Director |
Attribution de RSU |
45,000 |
- |
- |
45,000 |
| 2022-09-28 |
Kavuru Vimal |
Director |
Attribution de RSU |
45,000 |
- |
- |
45,000 |
| 2022-09-28 |
Olds Donald |
Director |
Attribution de RSU |
45,000 |
- |
- |
45,000 |
| 2022-09-28 |
Derby Michael |
Director |
Attribution de RSU |
85,000 |
- |
- |
85,000 |
| 2022-09-09 |
Kohli Prashant |
Cco |
Cession |
124,100 |
$1.63 |
$202.28K |
- |
| 2022-06-22 |
Lemieux Pierre |
COO, Canada & CSO |
Attribution de RSU |
165,000 |
- |
- |
165,000 |
| 2022-06-22 |
D'alvise Janelle |
President & CEO |
Attribution de RSU |
560,000 |
- |
- |
560,000 |
| 2022-06-22 |
Ford Brian D. |
Chief Financial Officer |
Attribution de RSU |
165,000 |
- |
- |
165,000 |
| 2022-06-22 |
Kottayil George |
COO, Us |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2022-03-24 |
Derby Michael |
Director |
Inconnu |
- |
- |
- |
- |
| 2021-11-12 |
Haseltine William A |
Director |
Attribution de RSU |
42,100 |
- |
- |
42,100 |
| 2021-11-12 |
Canan John |
Director |
Attribution de RSU |
42,100 |
$1.63 |
$68.62K |
42,100 |
| 2021-11-12 |
Kavuru Vimal |
Director |
Attribution de RSU |
42,100 |
- |
- |
42,100 |
| 2021-11-12 |
Lemieux Pierre |
COO, Canada & CSO |
Attribution de RSU |
287,900 |
- |
- |
287,900 |
| 2021-11-12 |
D'alvise Janelle |
President & CEO |
Attribution de RSU |
655,500 |
- |
- |
655,500 |
| 2021-11-12 |
Carter Roderick Noel |
Director |
Attribution de RSU |
42,100 |
- |
- |
42,100 |
| 2021-11-12 |
Olds Donald |
Director |
Attribution de RSU |
42,100 |
- |
- |
42,100 |
| 2021-11-12 |
Ford Brian D. |
Chief Financial Officer |
Attribution de RSU |
287,900 |
- |
- |
287,900 |
| 2021-11-10 |
Kottayil George |
COO, Us |
Cession |
287,900 |
$1.63 |
$469.28K |
- |
| 2021-08-27 |
Rajitha Grace 2018 Irrevocable Trust |
Director |
Cession |
- |
- |
- |
4,689,547 |
| 2021-08-27 |
Kavuru Vimal |
Director |
Inconnu |
- |
- |
- |
746,064 |
| 2021-08-27 |
Haseltine William A |
Director |
Cession |
- |
- |
- |
7,105 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi